Population and background
Unresectable locally advanced or recurrent head and neck cancer as defined by the Japanese approval documents.
What the evidence shows
The relevant medicine and devices have Japanese approval records. These help explain BNCT's mechanism and specific indications.
Conclusions that cannot be drawn
Japanese approval applies to a specific medicine-equipment combination. Enquiries in China still need to check the local basis for use and hospital assessment criteria. Approval records cannot predict individual efficacy.
Questions to ask your doctor
Do my lesion site, recurrence extent and prior radiotherapy meet this hospital's assessment criteria? What approvals support the proposed medicine and equipment, and where will monitoring and reassessment take place afterwards?